---
title: "Weekly Recap | Ocean Power Tech -49.25%, one-way slide as sector fades"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300850580.md"
description: "Ocean Power Tech (OPTT) fell 49.25% this week to $1.02, against a 0.27% decline for the S&P 500, underperforming by roughly 48.98 percentage points. The move was one-way lower: Monday opened at $1.96 and closed at $1.67, followed by three straight losing sessions. Thursday touched $1.000 intraday before Friday held a narrow $1.00-$1.11 range and settled at $1.02. Weekly amplitude came to 49.49% on elevated volume."
datetime: "2026-10-03T07:25:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300850580.md)
  - [en](https://longbridge.com/en/news/300850580.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300850580.md)
generator: "portal-rs"
---

# Weekly Recap | Ocean Power Tech -49.25%, one-way slide as sector fades

## The Week

Ocean Power Tech (OPTT) fell 49.25% this week to $1.02, against a 0.27% decline for the S&P 500, underperforming by roughly 48.98 percentage points. The move was one-way lower: Monday opened at $1.96 and closed at $1.67, followed by three straight losing sessions. Thursday touched $1.000 intraday before Friday held a narrow $1.00-$1.11 range and settled at $1.02. Weekly amplitude came to 49.49% on elevated volume.\\n\\n## Key Events\\n\\nNews this week centred on small-cap plays tied to AI integration and energy storage orders, with mentions of EIB settlement and Chilean orders as part of a cross-border capital chain. For Ocean Power itself, the most concrete item was a PRE 14A filing on 3 October covering proxy materials, a routine governance update. The same day, the company filed Form 3 for Chief Commercial Officer Jason Weed, disclosing shareholding details. No fresh operating or order announcement landed this week, so the price action looks tied to sector rotation and a pullback after earlier gains.\\n\\n## Analyst Ratings\\n\\nTwo analysts cover the stock, with both at buy and none at overweight, hold, underweight, sell or no opinion, giving a strong buy consensus. The consensus target is $45, about 4311.76% above the spot price of $1.02, and the high-low target range is also $45, so there is no visible dispersion. Within the heavy electrical equipment industry, the stock ranks 20th out of 20 names.\\n\\n## The Week Ahead\\n\\nMacro data dominates the coming days: the US S&P Global services PMI final and ISM non-manufacturing PMI land on Monday 5 October, trade balance figures follow on Tuesday 6 October, and EIA weekly crude and Cushing inventories arrive on Wednesday 7 October. These will shape broader market sentiment, while Ocean Power has no confirmed earnings or project milestone on the calendar yet.\\n\\n## In Short\\n\\nOcean Power had no direct operating catalyst this week, yet the stock slid 49.25% while the S&P 500 barely moved. The ratings picture is strikingly wide open on paper, with a consensus target far above spot, but the latest session’s large-lot flow tilted to net selling and the valuation stays thin, with negative P/E and PB around 1.09. The real test is whether actual orders or operating updates follow, rather than relying on the gap implied by the rating table.\\n\\n*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [OPTT.US](https://longbridge.com/en/quote/OPTT.US.md)

## Related News & Research

- [Ocean Power Technologies Lowers Note Conversion and Warrant Exercise Prices to $2.45](https://longbridge.com/en/news/300164588.md)
- [AI fever ignites a boom in thematic ETFs as fund managers hunt for their next big hit](https://longbridge.com/en/news/302963080.md)
- [NETWEB: Record Q2 results, led by AI Systems, with a ₹26,290 Mn order book](https://longbridge.com/en/news/302962323.md)
- [Amazon.com, Inc. $AMZN Stock Sold by Cohen Klingenstein LLC](https://longbridge.com/en/news/302980467.md)
- [MRNA: Intismeran plus pembrolizumab improved RFS and DMFS in resected melanoma](https://longbridge.com/en/news/302972013.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**